申请人:Pharmuka Laboratoires
公开号:US04613607A1
公开(公告)日:1986-09-23
Antiarhythmic medicaments containing, as active substance, a compound of the formula: ##STR1## in which n is 1 or 2, X and Y are fixed in positions 5, 6, 7 or 8 on the quinoline cycle and each represents a hydrogen atom or an alkoxy group having 1 to 3 carbons, R is a hydrogen atom or an alkyl group having 1 to 4 carbons, cycloalkyl having 3 to 8 carbons, phenyl or phenyl substituted by alkoxy having 1 to 4 carbons, R.sub.1 is a hydrogen atom or an alkyl group having 1 to 4 carbons or a phenylalkyl group of which the alkyl part has 1 to 3 carbons, R.sub.2 is a hydrogen atom, an alkyl group having 1 to 2 carbons or an alkenyl group having 2 to 4 carbons.
抗心律失常药物含有以下化合物作为活性物质:##STR1## 其中n为1或2,X和Y固定在喹啉环的5、6、7或8位置,每个代表一个氢原子或具有1至3个碳的烷氧基,R为氢原子或具有1至4个碳的烷基、具有3至8个碳的环烷基、苯基或被烷氧基取代的苯基,其烷氧基具有1至4个碳,R.sub.1是氢原子或具有1至4个碳的烷基或苯基烷基,其烷基部分具有1至3个碳,R.sub.2是氢原子、具有1至2个碳的烷基或具有2至4个碳的烯基。